CS245159B1 - A method for preparing a mixture of secondary anthraquinone metabolites - Google Patents
A method for preparing a mixture of secondary anthraquinone metabolites Download PDFInfo
- Publication number
- CS245159B1 CS245159B1 CS839012A CS901283A CS245159B1 CS 245159 B1 CS245159 B1 CS 245159B1 CS 839012 A CS839012 A CS 839012A CS 901283 A CS901283 A CS 901283A CS 245159 B1 CS245159 B1 CS 245159B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- mixture
- anthraquinone
- acetone
- metabolites
- solvent
- Prior art date
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Podstata sposobu tkvie v tom, že sa na kvapalnom médiu, obsahujúcom zdroje uhlíka, dusíka a minerálnych látok, kultivuje mikroorganizmus Trichoderma viride CCM F-742, potom sa mycélium a filtrát kultivačného média podrobí extrakci! organickým rozpúšťadlom typu chlórovaných uhlodovíkov, esterov kyseliny octovej alebo alifatických alkoholov obmedzene miešatelných s vodou, získaný extrakt sa po odpaření rozpúštadla rozpustí v acetone., adsorbuje sa na silikagél, eluuje zmesou benzén-acetón a zeluátu sa rozpúšťadlá odparia.The essence of the method lies in the fact that the microorganism Trichoderma viride CCM F-742 is cultivated on a liquid medium containing sources of carbon, nitrogen and mineral substances, then the mycelium and filtrate of the culture medium are subjected to extraction! with an organic solvent of the type of chlorinated hydrocarbons, acetic acid esters or aliphatic alcohols that are limitedly miscible with water, the obtained extract is dissolved in acetone after the solvent has evaporated, adsorbed on silica gel, eluted with a benzene-acetone mixture and the solvent is evaporated.
Description
Vynález sa týká sposobu přípravy zmesi sekundárných metabolitov atrachinónového typu.The invention relates to a process for preparing a mixture of atrachinone-type secondary metabolites.
Mnohé sekundárné metabolity mikroorganizmov sa vyznačujú biologickými účinkami a možno ich použit v boji proti patogénnym mikroorganizmom, parazitem, ako kancerostatiká a inak pósobiace farmakologicky účinné látky.Many secondary metabolites of microorganisms are characterized by biological effects and can be used to combat pathogenic microorganisms, parasites such as cancerostatics and otherwise acting pharmacologically active substances.
Niektoré z nich sa používajú ako východiskové zlúčeniny na přípravu semisyntetických derivátov S výhodnějšími alebo novými biologickými účinkami. Oblast použitia sekundárných metabolitov alebo ich semisyntetických derivátov s biologickou účinnosfiou zahrňuje humánnu a veterinárnu medicínu, rastlinnú a živočišnú výrobu, potravinárstvo a iné priemyselné výroby.Some of them are used as starting compounds for the preparation of semisynthetic derivatives with more advantageous or novel biological effects. The field of use of secondary metabolites or their semisynthetic derivatives with biological activity includes human and veterinary medicine, plant and animal production, food processing and other industrial production.
Medzi najvýznamnejšie sekundárné metabolity mikroorganizmov patria anitbiotiká a alkaloidy, ktoré majú najrozmenitejšie uplatnenie. V celom svete pokračuje vyhladávanie sekunrýrnych metabolitov mikroorganizmov a zistovanie možností ich praktického využitia.Among the most important secondary metabolites of microorganisms are anitbiotics and alkaloids, which have the most varied application. Searching for secular metabolites of microorganisms and exploring the possibilities of their practical use continue worldwide.
Rózne kmene mikroskopisekej huby Trichoderma viride produkujú sekundárné metabolity rozmanitej chemickej štruktúry, napr. peptidové suzukacilíny a alameticíny,, steroidný viridín, epiditiodioxopiperazínový gliotoxín a trichotecénový trichodermín /R. J. Cole and R. H. Coxi Handbook of toxic fungal metabolites, Academie Press, New York 1981, V. Betinai The chemistry and biology of antibiotics, Elsevier, Amsterdam 1983/.Different strains of Trichoderma viride microscopic fungus produce secondary metabolites of diverse chemical structures, e.g. peptide suzuucillins and alameticine, steroid viridine, epiditiodioxopiperazine gliotoxin and trichotecene trichodermin / R. J. Cole and R. H. Coxi Handbook of Toxic Fungal Metabolites, Academic Press, New York 1981, V. Betinai The Chemistry and Biology of Antibiotics, Elsevier, Amsterdam 1983 /.
Z bližšie necharakterizovaných kmeňov T. viride boli izolované aj deriváty antrachinónu - pachybazín /3-metyl-l-hydroxyantrachinón/ a emodín /3-metyl-l,6,8-trihydroxyantrachinón/ /C.-K. Wati Microbial quinones, in A. I. Laskin and H. A. Lechevalier, editorsi CRC Handbook of microbiology, vol. III, Microbial products, CSC Press lne., Cleveland, 1973, pp. 183 až 260/.Anthraquinone derivatives - pachybazine (3-methyl-1-hydroxyantraquinone) and emodine (3-methyl-1,6,8-trihydroxyantraquinone) / (C.-K) were also isolated from T. viride, which were not characterized further. Wati Microbial Quinones, in A.I. Laskin and H.A. Lechevalier, editors of the CRC Handbook of Microbiology, vol. III, Microbial products, CSC Press Inc., Cleveland, 1973, pp. 183-260].
Podlá PV 08189-83 autorov V. Betina a A. Fargašová mikroorganizmus Trichoderma viride CCM P-742 produkuje deriváty antrachinónu. AntrachinÓnové sekundárné metabolity majú rozmanité biologické účinky. Napr. antracyklínové antibiotíká sú kancerostatické a niektoré deriváty antrachinónu z húb mají antimikróbne, insektícídne /napr. rugulozín, J. Dobiáš, V. Betina a P. Nemec, Biológia 35 /1980/ 431 až 434 a iné biologické účinky.According to PV 08189-83 by V. Betina and A. Fargash microorganism Trichoderma viride CCM P-742 produces anthraquinone derivatives. Anthraquinone secondary metabolites have a variety of biological effects. E.g. anthracycline antibiotics are cancerostatic and some anthraquinone derivatives from fungi have antimicrobial, insecticidal / e.g. ruglozin, J. Dobias, V. Betina and P. Nemec, Biology 35/1980 / 431-434, and other biological effects.
Podstata sposobu přípravy zmesí sekundárných metabolitov antrachinónového typu podlá vynálezu spočívá v tom, že na kvapalnom médiu o p!t 6,0 až 6,5 obsahujúcom zdroje uhlíka, dusíka ako je kvasničný alebo kukuřičný extrakt a minerálnych látok, sa pri teplote 20 až 25 °C kultivuje mikroorganizmus Trichoderma viride CCM F-742 počas 15 až 25 dní, potom sa mycélium a filtrát kultivačného média podrobí extrakcii organickým rozpúštadlom typu chlórovaných uhlovodíkov, esterov kyseliny octovej alebo alifatických alkoholov obmedzene miešatelných s vodou, získaný extrakt sa po odpaření rozpúštadla rozpustí v acetone, adsorbuje na silikagél, eluuje zmesou benzén-acetón a z eluátu sa rozpúštadlá odparia.The process for preparing anthraquinone-type secondary metabolite mixtures according to the invention is characterized in that at a temperature of 20 to 25 ° C on a liquid medium again containing 6.0 to 6.5 containing sources of carbon, nitrogen such as yeast or corn extract and minerals, C cultures Trichoderma viride CCM F-742 for 15-25 days, then the mycelium and the culture medium filtrate are subjected to extraction with organic solvents such as chlorinated hydrocarbons, acetic acid esters or aliphatic alcohols limited to water miscibility, the extract obtained is dissolved in acetic acid It is adsorbed onto silica gel, eluted with a benzene-acetone mixture and the solvents are evaporated.
Surová zmes antrachinónových metabolitov z mycélia a kultivačného média sa rozpustí v acetone a adsorbuje sa na 5-násobné množstvo silikagélu odpařením rozpúštadla za zníženého tlaku. AntrachinÓnové metabolity adsorbované na silikagéli sa nanesú na štipec silikagélu připravený suspendováním silikagélu v zmesi benzén-acetón. Elúciou zmesou benzén-acetón /lil alebo 2«3/ sa získá zmes antrachinónových metabolitov.The crude mixture of anthraquinone metabolites from mycelium and culture medium is dissolved in acetone and adsorbed onto a 5-fold amount of silica gel by evaporation of the solvent under reduced pressure. The anthraquinone metabolites adsorbed onto silica gel are loaded onto a silica gel column prepared by suspending the silica gel in a benzene-acetone mixture. Elution with benzene-acetone (III or 2: 3) gave an anthraquinone metabolite mixture.
Zmes sa nerozpúšta vo vodě, rozpúšta se v metanole, acetone, octane etylnatom a chloroforme, slabo sa rozpúšta v benzéne, Zmes sa dá kvalitativně rozdělit tenkovrstvou chromatogr af iou na niekolko zložiek.The mixture does not dissolve in water, dissolves in methanol, acetone, ethyl acetate and chloroform, weakly dissolves in benzene. The mixture can be qualitatively separated by thin-layer chromatography into several components.
Uvedená zmes slúži ako východiskový materiál na přípravu čistých látok antrachinónového typu.Said mixture serves as a starting material for the preparation of pure anthraquinone-type substances.
Příklad 1 kusov 1 000 ml Erlenmyerových baniek sa naplní po 300 ml kultivačného roztoku tohto zloženíai sacharóza 40 g, dusičnan sodný 3 g, hydrogénfosforečnan draselný 1 g, síran horečnatý 0,5 g, chlorid draselný 0,5 g, síran železnatý 0,01 g, kvasničný atuolyzát 5 g a 1 000 ml pitnej vody, pH před sterilizáciou 6,0 až 6,5. Sterilizuje sa pri 120 °C.Example 1 pieces 1000 ml Erlenmyer flasks are filled with 300 ml of a culture solution of this composition: sucrose 40 g, sodium nitrate 3 g, potassium hydrogen phosphate 1 g, magnesium sulfate 0.5 g, potassium chloride 0.5 g, ferrous sulfate 0.01 g, yeast atuolysate 5 g and 1000 ml drinking water, pH before sterilization 6.0 to 6.5. Sterilize at 120 ° C.
V kultivačných nádobách sa roztok naočkuje po 4 ml suspenzie spor mikroorganizmu Trichoderma viride CCM F-742, ktorá sa připraví zalitím vysporulovanej kultúry v 1 000 ml Erlenmayerových bankách po 125 ml sterilného 0,05 % vodného roztoku Tween 80 a uvolněním spor sterilnou skleněnou, tyčinkou. Kultivačně nádoby sa inkubujú pri laboratórnej teplote staticky za stálého osvetlenia alebo za striedanie dňa a noci 21 dní, keď sa dosiahne maximum produkcie antrachinónových metabolitov.In the culture flasks, the solution is inoculated with 4 ml of a spore suspension of Trichoderma viride CCM F-742, which is prepared by pouring the spore culture in 1,000 ml Erlenmeyer flasks with 125 ml sterile 0.05% aqueous Tween 80 solution and releasing the spores with a sterile glass rod. . The culture flasks are incubated at room temperature statically under constant illumination or alternating day and night for 21 days when maximum production of anthraquinone metabolites is reached.
Příklad 2Example 2
Kultivačně médium po kultivácii kmeňa Trichoderma viride podlá příkladu 1 sa opatrene zleje a přefiltruje. Mycelium v Erlenmayerových bankách sa žaleje po 200 ml octanu etylnatého, ktorý sa nechá pósobiť 16 až 24 hodin pri laboratórnej teplote. Potom sa mycélium oddělí od extraktu vákuovou filtráciou a spojené extrakty sa zbavia vody filtráciou cez bezvodý síran sodný a získaný filtrát sa odpaří za zníženého tlaku. Získá sa 6 g surového preparátu.The culture medium after cultivation of the Trichoderma viride strain of Example 1 is carefully decanted and filtered. The mycelium in Erlenmeyer flasks are coated with 200 ml of ethyl acetate, which is left to work for 16 to 24 hours at room temperature. The mycelium is then separated from the extract by vacuum filtration and the combined extracts are dewatered by filtration over anhydrous sodium sulfate and the filtrate obtained is evaporated under reduced pressure. 6 g of crude preparation are obtained.
Príklad3Example 3
K 12 1 filtrátu kultivačného média získaného podlá příkladu 2 sa přidá 6 litrov octanu etylnatého, dokladné sa premieša miešadlom po dobu 20 min a,obe fázy sa oddelia. K vodnej fáze sa pridajú 3 1 octanu etylnatého a postupuje sa ako pri prvej extrakci!. Spojené octové fázy sa zbavia vody filtráciou cez vrstvu bezvodého síranu sodného a získaný filtrát sa odpaří do sucha za zníženého tlaku. Získá sa 1 g surového preparátu.To 12 l of the culture medium filtrate obtained according to Example 2, 6 liters of ethyl acetate are added, mixed thoroughly with a stirrer for 20 minutes and the two phases are separated. 3 L of ethyl acetate is added to the aqueous phase and the procedure is as for the first extraction. The combined acetic phases are dehydrated by filtration through a pad of anhydrous sodium sulfate and the filtrate is evaporated to dryness under reduced pressure. 1 g of crude preparation is obtained.
Príklad4 g surového preparátu, získaného z mycélia podlá příkladu 2 a z filtrátu kultivačného média podlá příkladu 3 sa extrahuje 200 ml n-hexánu, extrakt sa odfiltruje a rozpúšťadlo sa odpaří za zníženého tlaku. Získá sa 4,45 g olejovitej zložky, ktorá sa ďalej nespracúva. Zvyšok surového preparátu sa extrahuje 1 000 ml octanu etylnatého, extrakt sa sfiltruje a rozpúšťadlo sa odpaří za zníženého tlaku. Získá sa 1 g surověj zmesi antrachinónových metabolitov.EXAMPLE 4 g of the crude preparation obtained from the mycelium of Example 2 and the culture medium filtrate of Example 3 are extracted with 200 ml of n-hexane, the extract is filtered off and the solvent is evaporated off under reduced pressure. 4.45 g of an oily component are obtained, which is not further processed. The residue of the crude preparation is extracted with 1000 ml of ethyl acetate, the extract is filtered and the solvent is evaporated under reduced pressure. 1 g of a crude mixture of anthraquinone metabolites is obtained.
Surová zmes sa rozpustí v acetone, přidá se 5 g silikagélu a za zníženého tlaku sa rozpúšťadlo odpaří. Silikagél s adsorbovanými metabolitmi sa nanesie na štipec silikagélu 3 x 30 cm, suspendovaného v zmesi benzén-acetón /95>5/, a eluuje sa zmesou benzén-acetón /1>1 až 2í3/. Zachytí sa frakcia žltavého až oranžového sfarbenia, ktorá obsahuje 6,5 g zmesi antrachinónových metabolitov.The crude mixture was dissolved in acetone, 5 g of silica gel was added and the solvent was evaporated under reduced pressure. The silica gel with adsorbed metabolites is loaded onto a 3 x 30 cm silica gel slurry suspended in benzene-acetone (95> 5) and eluted with benzene-acetone (1> 1-23). A yellow to orange fraction containing 6.5 g of anthraquinone metabolite mixture was collected.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS839012A CS245159B1 (en) | 1983-12-02 | 1983-12-02 | A method for preparing a mixture of secondary anthraquinone metabolites |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS839012A CS245159B1 (en) | 1983-12-02 | 1983-12-02 | A method for preparing a mixture of secondary anthraquinone metabolites |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CS901283A1 CS901283A1 (en) | 1985-12-16 |
| CS245159B1 true CS245159B1 (en) | 1986-08-14 |
Family
ID=5441427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS839012A CS245159B1 (en) | 1983-12-02 | 1983-12-02 | A method for preparing a mixture of secondary anthraquinone metabolites |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS245159B1 (en) |
-
1983
- 1983-12-02 CS CS839012A patent/CS245159B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CS901283A1 (en) | 1985-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS61118387A (en) | Novel antibiotic compound and manufacture | |
| JPH05502163A (en) | new product | |
| CZ390592A3 (en) | Process for preparing 4,5-dihydrogendanamycin and hydroquinone thereof and the use of such compounds | |
| EP0254583A2 (en) | Parasiticidal milbemycin derivatives, a process for their production, and compositions containing the same | |
| KR960012212B1 (en) | Herbicide, its preparation and use | |
| PETERSEN et al. | Production of cladospirone bisepoxide, a new fungal metabolite | |
| US10793824B2 (en) | Salt formulations for the fermentation of marine microorganisms | |
| EP0048585A1 (en) | Antibiotics TM-531 B and TM-531 C | |
| US3869277A (en) | Herbicidal composition and methods | |
| JPS61216692A (en) | Cl-1577-b4 compound and its production | |
| US4148881A (en) | Miticidal compositions comprising antibiotic K-41 | |
| JPS6010718B2 (en) | Process for producing maytansinol, maytanacin and maytansinol propionate | |
| US3767799A (en) | Antibiotic proticin | |
| Pocard et al. | Translocation and metabolism of glycine betaine in nodulated alfalfa plants subjected to salt stress | |
| EP1118617B1 (en) | Compounds with an antioxidant acitivity, compositions useful as food integrators containing them and process for their preparation | |
| US3992552A (en) | Antibiotic substance B-41, their production and their use as insecticides and acaricides | |
| Ciegler et al. | An antibiotic complex from Alternaria brassicicola | |
| EP0232572A2 (en) | New agrochemical named "Substance No. 51262", its preparation and use | |
| US3966914A (en) | Antibiotic substances B-41, their production and their use as insecticides and acaricides | |
| US3089816A (en) | Lemacidine and process for its manufacture | |
| CN120574273B (en) | Blastocin, its application and preparation method, pesticide agent and method for preventing and controlling rice blast | |
| US2990330A (en) | Streptomyces griseus strain 528 nrrl 2607 antibiotic and fermentation process | |
| EP0046641A2 (en) | Novel antibiotics, the microbiological preparation of antibiotics, and a novel microorganism | |
| CA1113874A (en) | Antibiotic bl580 zeta from streptomyces hydroscopicus | |
| JPH0347184A (en) | diazepine herbicide |